Sales 2026 by Business Segment

Sales 2026 by Geography

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (INR)
Fiscal Period: March 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Pharmaceutical Products

          

Generic Formulation Business

8.51TCr 9.62TCr 11TCr 12TCr 14TCr

Total Assets

13TCr 15TCr 15TCr 15TCr 44TCr

Interest Expense

-252.93Cr -332.24Cr -352.63Cr -251.38Cr -384.69Cr

Income Tax Expense

448.73Cr 601.93Cr 695.73Cr 761.56Cr 734.01Cr

CAPEX

-202.57Cr -573.94Cr -432.78Cr -611.87Cr -677.39Cr

EBT

1.23TCr 1.85TCr 2.35TCr 2.67TCr 2.87TCr

D&A

642.65Cr 683Cr 774.84Cr 774Cr 1.1TCr

Net Income

777.18Cr 1.25TCr 1.66TCr 1.91TCr 2.16TCr

Geographical Revenue Distribution History

Geographical breakdown of sales (INR)
Fiscal Period: March 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

India

4.68TCr 5.37TCr 6.11TCr 6.79TCr 8.16TCr

Total Assets

6.84TCr 8.68TCr 8.22TCr 7.99TCr 33TCr

Other Countries

1.05TCr 1.23TCr 1.34TCr 1.39TCr 1.84TCr

Total Assets

62Cr 61Cr 47Cr 73Cr 197.47Cr

Total Assets

- - - 206.65Cr 245.44Cr

United States

1.07TCr 1.16TCr 1.08TCr 1.1TCr 1.36TCr

Total Assets

66Cr 29Cr 27Cr 39Cr 89Cr

Brazil

742.04Cr 935.46Cr 1.13TCr 1.1TCr 1.36TCr

Total Assets

24Cr 35Cr 55Cr 90Cr 147.47Cr

Germany

966.31Cr 927.69Cr 1.07TCr 1.14TCr 1.25TCr

Total Assets

83Cr 100.98Cr 162Cr 66Cr 85Cr